检索范围:
排序: 展示方式:
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
《医学前沿(英文)》 2022年 第16卷 第3期 页码 416-428 doi: 10.1007/s11684-021-0838-5
关键词: abivertinib Btk inhibitor platelet megakaryocyte megakaryopoiesis thrombopoiesis
Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions
null
《医学前沿(英文)》 2018年 第12卷 第2期 页码 139-152 doi: 10.1007/s11684-017-0551-6
Current research on common musculoskeletal problems, including osteoarticular conditions, tendinopathies, and muscle injuries, focuses on regenerative translational medicine. Platelet-rich plasma therapies have emerged as a potential approach to enhance tissue repair and regeneration. Platelet-rich plasma application aims to provide supraphysiological concentrations of platelets and optionally leukocytes at injured/pathological tissues mimicking the initial stages of healing. However, the efficacy of platelet-rich plasma is controversial in chronic diseases because patients’ outcomes show partial improvements. Platelet-rich plasma can be customized to specific conditions by selecting the most appropriate formulation and timing for application or by combining platelet-rich plasma with synergistic or complementary treatments. To achieve this goal, researchers should identify and enhance the main mechanisms of healing. In this review, the interactions between platelet-rich plasma and healing mechanisms were addressed and research opportunities for customized treatment modalities were outlined. The development of combinational platelet-rich plasma treatments that can be used safely and effectively to manipulate healing mechanisms would be valuable and would provide insights into the processes involved in physiological healing and pathological failure.
关键词: regenerative medicine joint conditions muscle injuries platelet rich plasma tendinopathy healing mechanisms
Engineering platelet-mimicking drug delivery vehicles
Quanyin Hu, Hunter N. Bomba, Zhen Gu
《化学科学与工程前沿(英文)》 2017年 第11卷 第4期 页码 624-632 doi: 10.1007/s11705-017-1614-6
关键词: drug delivery platelets nanomedicine bio-inspired biomimetic
Yinlong Zhang, Guangna Liu, Jingyan Wei, Guangjun Nie
《医学前沿(英文)》 2018年 第12卷 第6期 页码 667-677 doi: 10.1007/s11684-017-0583-y
关键词: platelet-mimicking delivery systems tumor-associated platelets cancer therapy EPR effect
Guocheng LIU MD, Shouhua YANG MD, Zehua WANG MD,
《医学前沿(英文)》 2009年 第3卷 第4期 页码 447-451 doi: 10.1007/s11684-009-0082-x
关键词: cervical cancer lymphatic vessel density blood vessel density platelet-derived growth factor
null
《医学前沿(英文)》 2016年 第10卷 第1期 页码 76-84 doi: 10.1007/s11684-015-0426-7
Anti-β2 glycoprotein I (anti-β2GP I ) antibodies are important contributors to thrombosis, especially in patients with antiphospholipid syndrome (APS). However, the mechanism by which anti-β2GP I antibodies are involved in the pathogenesis of thrombosis is not fully understood. In this report, we investigated the role of anti-β2GP I antibodies in complexes with β2GP I as mediators of platelet activation, which can serve as a potential source contributing to thrombosis. We examined the involvement of the apolipoprotein E receptor 2' (apoER2') and glycoprotein I ba (GP I bα) in platelet activation induced by the anti-β2GP I /β2GP I complex. The interaction between the anti-β2GP I /β2GP I complex and platelets was examined using in vitro methods, in which the Fc portion of the antibody was immobilized using protein A coated onto a microtiter plate. Platelet activation was assessed by measuring GP II b/ III a activation and P-selectin expression and thromboxane B2 production as well as p38 mitogen-activated protein kinase phosphorylation. Our results revealed that the anti-β2GP I /β2GP I complex was able to activate platelets, and this activation was inhibited by either the anti-GP I bα antibody or the apoER2' inhibitor. Results showed that the anti-β2GP I /β2GP I complex induced platelet activation via GP I bα and apoER2', which may then contribute to the prothrombotic tendency in APS patients.
关键词: anti-β2GP I /β2GP I complex platelet GP I bα apoER2' thrombosis
Jing YANG,Juan LV,Bin GAO,Li ZHANG,Dazhi YANG,Changcan SHI,Jintang GUO,Wenzhong LI,Yakai FENG
《化学科学与工程前沿(英文)》 2014年 第8卷 第2期 页码 188-196 doi: 10.1007/s11705-014-1414-1
关键词: poly(ethylene glycol) monoacrylate phosphorylcholine polycarbonateurethane surface modification anti-platelet adhesion biomaterials
XIA Dasheng, SONG Yanqiu, LI Chao, ZHANG Feng, WEI Minxin
《医学前沿(英文)》 2007年 第1卷 第4期 页码 352-355 doi: 10.1007/s11684-007-0067-6
Expression of protease-activated receptors on platelets in healthy individuals
Rui ZHU, Lin SHEN
《医学前沿(英文)》 2009年 第3卷 第2期 页码 236-239 doi: 10.1007/s11684-009-0040-7
GONG Xiaowei, WEI Jie, LI Yusheng, CHENG Weiwei, DENG Peng, JIANG Yong
《医学前沿(英文)》 2007年 第1卷 第3期 页码 248-252 doi: 10.1007/s11684-007-0047-x
关键词: control stimulation mitogen-activated growth factor process
Anti-β2GPI/β2GPI complexes induce platelet activation and promote thrombosis via
Wenjing Zhang, Caijun Zha, Xiumin Lu, Ruichun Jia, Fei Gao, Qi Sun, Meili Jin, Yanhong Liu
《医学前沿(英文)》 2019年 第13卷 第6期 页码 680-689 doi: 10.1007/s11684-018-0673-5
关键词: anti-
工程化仿生血小板膜包覆纳米颗粒阻断金黄色葡萄球菌的细胞毒性并防止致命的全身感染 Article
Jwa-Kyung Kim, Satoshi Uchiyama, Hua Gong, Alexandra Stream, Liangfang Zhang, Victor Nizet
《工程(英文)》 2021年 第7卷 第8期 页码 1149-1156 doi: 10.1016/j.eng.2020.09.013
金黄色葡萄球菌(S. aureus)是一种常见的人类病原体,它可以引发严重的侵袭性感染,如菌血症、败血症和心内膜炎,具有较高的发病率和死亡率。然而由于细菌的抗生素耐药性增强,如耐甲氧西林金黄色葡萄球菌(MRSA),加剧了此类细菌的发病率和死亡率。金黄色葡萄球菌的发病机制是由毒素的分泌推动的,如膜损伤孔α毒素,它有不同的细胞靶点,包括上皮细胞、内皮细胞、白细胞和血小板。本文采用人体血小板膜包覆纳米颗粒(PNP)作为一种仿生诱饵策略,来中和金黄色葡萄球菌的毒素,并维持宿主细胞的防御功能。血小板膜包覆纳米颗粒保护血小板免受由金黄色葡萄球菌毒素带来的损伤,维持血小板活化和杀菌活性。血小板膜包覆纳米颗粒也同样保护巨噬细胞免受由金黄色葡萄球菌毒素带来的损伤,支持巨噬细胞进行氧化迸发、产生一氧化氮和维持其杀菌活性,并减少耐甲氧西林金黄色葡萄球菌诱导的中性粒细胞胞外杀菌网络。在感染系统性耐甲氧西林金黄色葡萄球菌的小鼠模型中,血小板膜包覆纳米颗粒制剂减少了血液中的细菌数量并防止小鼠发生死亡。总之,目前的研究结果证明了血小板膜包覆纳米颗粒的治疗优点,如中和毒素、保护细胞和增加宿主对侵袭性金黄色葡萄球菌感染的抵抗力。
Plasma-enabled healing of graphene nano-platelets layer
Xiuqi Fang, Carles Corbella, Denis B. Zolotukhin, Michael Keidar
《化学科学与工程前沿(英文)》 2019年 第13卷 第2期 页码 350-359 doi: 10.1007/s11705-018-1787-7
关键词: graphene platelet networks anodic arc discharge plasma healing scanning electron microscopy Raman spectroscopy
标题 作者 时间 类型 操作
Platelet membrane-based and tumor-associated platelet- targeted drug delivery systems for cancer therapy
Yinlong Zhang, Guangna Liu, Jingyan Wei, Guangjun Nie
期刊论文
The relationship between platelet-derived growth factor expression and angiogenesis/lymphangiogenesis
Guocheng LIU MD, Shouhua YANG MD, Zehua WANG MD,
期刊论文
Anti-β glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two
null
期刊论文
polycarbonateurethane surface with poly(ethylene glycol) monoacrylate and phosphorylcholine glyceraldehyde for anti-platelet
Jing YANG,Juan LV,Bin GAO,Li ZHANG,Dazhi YANG,Changcan SHI,Jintang GUO,Wenzhong LI,Yakai FENG
期刊论文
The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with
XIA Dasheng, SONG Yanqiu, LI Chao, ZHANG Feng, WEI Minxin
期刊论文
Expression of protease-activated receptors on platelets in healthy individuals
Rui ZHU, Lin SHEN
期刊论文
Involvement of p38 mitogen-activated protein kinase in the regulation of platelet-derived growth factor
GONG Xiaowei, WEI Jie, LI Yusheng, CHENG Weiwei, DENG Peng, JIANG Yong
期刊论文
Anti-β2GPI/β2GPI complexes induce platelet activation and promote thrombosis via
Wenjing Zhang, Caijun Zha, Xiumin Lu, Ruichun Jia, Fei Gao, Qi Sun, Meili Jin, Yanhong Liu
期刊论文
工程化仿生血小板膜包覆纳米颗粒阻断金黄色葡萄球菌的细胞毒性并防止致命的全身感染
Jwa-Kyung Kim, Satoshi Uchiyama, Hua Gong, Alexandra Stream, Liangfang Zhang, Victor Nizet
期刊论文